Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fagan

Showing results (241-250 of 489) with videos related to

Pageof 49
Sort By:
Journal of Alzheimer'S Disease : JAD|April 23, 2016
Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future "Non-Cognitive" Outcomes of Alzheimer's DiseaseAdam P Ingber, Jason Hassenstab, Anne M Fagan, et al.
Artificial Intelligence in Medicine|February 1, 1993
The design and implementation of a ventilator-management advisorG W Rutledge, G E Thomsen, B R Farr, et al.
Psychology and Aging|April 17, 2023
Increased cognitive effort costs in healthy aging and preclinical Alzheimer's diseaseAndrew J Aschenbrenner, Jennifer L Crawford, Jonathan E Peelle, et al.
Neurobiology of Aging|February 25, 2015
Task-evoked fMRI changes in attention networks are associated with preclinical Alzheimer's disease biomarkersBrian A Gordon, Jeffrey M Zacks, Tyler Blazey, et al.
Archives of Neurology|May 11, 2011
Comparison of analytical platforms for cerebrospinal fluid measures of β-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathologyAnne M Fagan, Leslie M Shaw, Chengjie Xiong, et al.
Journal of Alzheimer'S Disease : JAD|March 8, 2020
Resting State Functional Connectivity Signature Differentiates Cognitively Normal from Individuals Who Convert to Symptomatic Alzheimer's DiseaseJulie K Wisch, Catherine M Roe, Ganesh M Babulal, et al.
JAMA Neurology|March 13, 2013
Sleep quality and preclinical Alzheimer diseaseYo-El S Ju, Jennifer S McLeland, Cristina D Toedebusch, et al.
Journal of Alzheimer'S Disease : JAD|April 24, 2023
Comparing Tau PET Visual Interpretation with Tau PET Quantification, Cerebrospinal Fluid Biomarkers, and Longitudinal Clinical AssessmentCharles D Chen, Maria Rosana Ponisio, Jordan A Lang, et al.
Proteomics. Clinical Applications|December 8, 2010
Identification and validation of novel CSF biomarkers for early stages of Alzheimer's diseaseYan Hu, Ava Hosseini, John S K Kauwe, et al.
Alzheimer Disease and Associated Disorders|March 27, 2018
Alzheimer Disease Biomarkers and Driving in Clinically Normal Older Adults: Role of Spatial Navigation AbilitiesSamantha Allison, Ganesh M Babulal, Sarah H Stout, et al.
Pageof 49

Showing results (241-250 of 489) with videos related to

Sort By:
Pageof 49
Journal of Alzheimer'S Disease : JAD|April 23, 2016
Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future "Non-Cognitive" Outcomes of Alzheimer's DiseaseAdam P Ingber, Jason Hassenstab, Anne M Fagan, et al.
Artificial Intelligence in Medicine|February 1, 1993
The design and implementation of a ventilator-management advisorG W Rutledge, G E Thomsen, B R Farr, et al.
Psychology and Aging|April 17, 2023
Increased cognitive effort costs in healthy aging and preclinical Alzheimer's diseaseAndrew J Aschenbrenner, Jennifer L Crawford, Jonathan E Peelle, et al.
Neurobiology of Aging|February 25, 2015
Task-evoked fMRI changes in attention networks are associated with preclinical Alzheimer's disease biomarkersBrian A Gordon, Jeffrey M Zacks, Tyler Blazey, et al.
Archives of Neurology|May 11, 2011
Comparison of analytical platforms for cerebrospinal fluid measures of β-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathologyAnne M Fagan, Leslie M Shaw, Chengjie Xiong, et al.
Journal of Alzheimer'S Disease : JAD|March 8, 2020
Resting State Functional Connectivity Signature Differentiates Cognitively Normal from Individuals Who Convert to Symptomatic Alzheimer's DiseaseJulie K Wisch, Catherine M Roe, Ganesh M Babulal, et al.
JAMA Neurology|March 13, 2013
Sleep quality and preclinical Alzheimer diseaseYo-El S Ju, Jennifer S McLeland, Cristina D Toedebusch, et al.
Journal of Alzheimer'S Disease : JAD|April 24, 2023
Comparing Tau PET Visual Interpretation with Tau PET Quantification, Cerebrospinal Fluid Biomarkers, and Longitudinal Clinical AssessmentCharles D Chen, Maria Rosana Ponisio, Jordan A Lang, et al.
Proteomics. Clinical Applications|December 8, 2010
Identification and validation of novel CSF biomarkers for early stages of Alzheimer's diseaseYan Hu, Ava Hosseini, John S K Kauwe, et al.
Alzheimer Disease and Associated Disorders|March 27, 2018
Alzheimer Disease Biomarkers and Driving in Clinically Normal Older Adults: Role of Spatial Navigation AbilitiesSamantha Allison, Ganesh M Babulal, Sarah H Stout, et al.
Pageof 49